482 related articles for article (PubMed ID: 25209898)
1. MeCP2 deficiency is associated with reduced levels of tubulin acetylation and can be restored using HDAC6 inhibitors.
Gold WA; Lacina TA; Cantrill LC; Christodoulou J
J Mol Med (Berl); 2015 Jan; 93(1):63-72. PubMed ID: 25209898
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of HDAC6 deacetylase activity increases its binding with microtubules and suppresses microtubule dynamic instability in MCF-7 cells.
Asthana J; Kapoor S; Mohan R; Panda D
J Biol Chem; 2013 Aug; 288(31):22516-26. PubMed ID: 23798680
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic factors MeCP2 and HDAC6 control α-tubulin acetylation in cardiac fibroblast proliferation and fibrosis.
Tao H; Yang JJ; Shi KH; Li J
Inflamm Res; 2016 May; 65(5):415-26. PubMed ID: 26975406
[TBL] [Abstract][Full Text] [Related]
4. Selective HDAC6 inhibition prevents TNF-α-induced lung endothelial cell barrier disruption and endotoxin-induced pulmonary edema.
Yu J; Ma Z; Shetty S; Ma M; Fu J
Am J Physiol Lung Cell Mol Physiol; 2016 Jul; 311(1):L39-47. PubMed ID: 27190059
[TBL] [Abstract][Full Text] [Related]
5. HDAC6 inhibition results in tau acetylation and modulates tau phosphorylation and degradation in oligodendrocytes.
Noack M; Leyk J; Richter-Landsberg C
Glia; 2014 Apr; 62(4):535-47. PubMed ID: 24464872
[TBL] [Abstract][Full Text] [Related]
6. HDAC inhibitor ameliorates behavioral deficits in Mecp2
Lebrun N; Delépine C; Selloum M; Meziane H; Nectoux J; Herault Y; Bienvenu T
Brain Res; 2021 Dec; 1772():147670. PubMed ID: 34582789
[TBL] [Abstract][Full Text] [Related]
7. A selective histone deacetylase-6 inhibitor improves BDNF trafficking in hippocampal neurons from Mecp2 knockout mice: implications for Rett syndrome.
Xu X; Kozikowski AP; Pozzo-Miller L
Front Cell Neurosci; 2014; 8():68. PubMed ID: 24639629
[TBL] [Abstract][Full Text] [Related]
8. Altered microtubule dynamics and vesicular transport in mouse and human MeCP2-deficient astrocytes.
Delépine C; Meziane H; Nectoux J; Opitz M; Smith AB; Ballatore C; Saillour Y; Bennaceur-Griscelli A; Chang Q; Williams EC; Dahan M; Duboin A; Billuart P; Herault Y; Bienvenu T
Hum Mol Genet; 2016 Jan; 25(1):146-57. PubMed ID: 26604147
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of HDAC6 by tubastatin A disrupts mouse oocyte meiosis via regulating histone modifications and mRNA expression.
Sui L; Huang R; Yu H; Zhang S; Li Z
J Cell Physiol; 2020 Oct; 235(10):7030-7042. PubMed ID: 32017059
[TBL] [Abstract][Full Text] [Related]
10. Activation of histone deacetylase-6 induces contractile dysfunction through derailment of α-tubulin proteostasis in experimental and human atrial fibrillation.
Zhang D; Wu CT; Qi X; Meijering RA; Hoogstra-Berends F; Tadevosyan A; Cubukcuoglu Deniz G; Durdu S; Akar AR; Sibon OC; Nattel S; Henning RH; Brundel BJ
Circulation; 2014 Jan; 129(3):346-58. PubMed ID: 24146251
[TBL] [Abstract][Full Text] [Related]
11. Selective inhibitor of histone deacetylase 6 (tubastatin A) suppresses proliferation of hepatitis C virus replicon in culture of human hepatocytes.
Kozlov MV; Kleymenova AA; Konduktorov KA; Malikova AZ; Kochetkov SN
Biochemistry (Mosc); 2014 Jul; 79(7):637-42. PubMed ID: 25108326
[TBL] [Abstract][Full Text] [Related]
12. Domain-selective small-molecule inhibitor of histone deacetylase 6 (HDAC6)-mediated tubulin deacetylation.
Haggarty SJ; Koeller KM; Wong JC; Grozinger CM; Schreiber SL
Proc Natl Acad Sci U S A; 2003 Apr; 100(8):4389-94. PubMed ID: 12677000
[TBL] [Abstract][Full Text] [Related]
13. MeCP2 deficiency is associated with impaired microtubule stability.
Delépine C; Nectoux J; Bahi-Buisson N; Chelly J; Bienvenu T
FEBS Lett; 2013 Jan; 587(2):245-53. PubMed ID: 23238081
[TBL] [Abstract][Full Text] [Related]
14. Tubastatin ameliorates pulmonary fibrosis by targeting the TGFβ-PI3K-Akt pathway.
Saito S; Zhuang Y; Shan B; Danchuk S; Luo F; Korfei M; Guenther A; Lasky JA
PLoS One; 2017; 12(10):e0186615. PubMed ID: 29045477
[TBL] [Abstract][Full Text] [Related]
15. HDAC6 regulates epidermal growth factor receptor (EGFR) endocytic trafficking and degradation in renal epithelial cells.
Liu W; Fan LX; Zhou X; Sweeney WE; Avner ED; Li X
PLoS One; 2012; 7(11):e49418. PubMed ID: 23152903
[TBL] [Abstract][Full Text] [Related]
16. HDAC6 inhibition by tubastatin A is protective against oxidative stress in a photoreceptor cell line and restores visual function in a zebrafish model of inherited blindness.
Leyk J; Daly C; Janssen-Bienhold U; Kennedy BN; Richter-Landsberg C
Cell Death Dis; 2017 Aug; 8(8):e3028. PubMed ID: 29048427
[TBL] [Abstract][Full Text] [Related]
17. SIRT2 inactivation reveals a subset of hyperacetylated perinuclear microtubules inaccessible to HDAC6.
Skoge RH; Ziegler M
J Cell Sci; 2016 Aug; 129(15):2972-82. PubMed ID: 27311481
[TBL] [Abstract][Full Text] [Related]
18. Histone deacetylase 6 inhibits influenza A virus release by downregulating the trafficking of viral components to the plasma membrane via its substrate, acetylated microtubules.
Husain M; Cheung CY
J Virol; 2014 Oct; 88(19):11229-39. PubMed ID: 25031336
[TBL] [Abstract][Full Text] [Related]
19. HDAC6 is a microtubule-associated deacetylase.
Hubbert C; Guardiola A; Shao R; Kawaguchi Y; Ito A; Nixon A; Yoshida M; Wang XF; Yao TP
Nature; 2002 May; 417(6887):455-8. PubMed ID: 12024216
[TBL] [Abstract][Full Text] [Related]
20. Tubastatin A, an HDAC6 inhibitor, alleviates stroke-induced brain infarction and functional deficits: potential roles of α-tubulin acetylation and FGF-21 up-regulation.
Wang Z; Leng Y; Wang J; Liao HM; Bergman J; Leeds P; Kozikowski A; Chuang DM
Sci Rep; 2016 Jan; 6():19626. PubMed ID: 26790818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
